文献速递新发突发、热带与寄生虫病

低剂量他非诺喹在实验性感染恶性疟原虫的健康志愿者中的传播阻断活性

Transmission Blocking Activity of Low-dose Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum.
PubMed 文献 · Clin Infect Dis · 2023-01-01

健康成人接种恶性疟原虫3D7株感染红细胞后,用哌喹清除无性体血症,第25天单次口服50 mg他非诺喹。6名受试者用药前均对蚊媒具感染性,用药后第4天卵囊和子孢子阳性率中位分别降低35%和52%,第7天分别降低81%和77%,配子体密度下降无显著意义,未发现显著安全性问题。

要点

  • 6名健康志愿者实验性感染恶性疟原虫后单次口服50 mg他非诺喹。
  • 用药后第7天蚊媒卵囊阳性率中位降低81%,子孢子阳性率中位降低77%。
  • 他非诺喹降低配子体密度的作用未达统计学显著,传播阻断效应有延迟。

核心结论

  • 低剂量他非诺喹(50 mg)可降低恶性疟原虫向蚊媒的传播,但效应有延迟。

研究设计与样本

  • 健康成人于第0天接种恶性疟原虫3D7株感染红细胞,第9天和第11天给予哌喹清除无性体血症,第25天单次口服50 mg他非诺喹,共纳入6名受试者。

主要发现

  • 用药前6名受试者均对蚊媒具感染性,蚊媒卵囊阳性率中位86%(范围22-98),子孢子阳性率中位57%(范围4-92)。
  • 用药后第4天卵囊阳性率中位降低35%(四分位距16-46),子孢子阳性率中位降低52%(四分位距40-62)。
  • 用药后第7天卵囊阳性率中位降低81%(四分位距36-92),子孢子阳性率中位降低77%(四分位距52-98)。
  • 他非诺喹用药后配子体密度下降无显著意义,未发现显著的安全性顾虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Blocking the transmission of parasites from humans to mosquitoes is a key component of malaria control. Tafenoquine exhibits activity against all stages of the malaria parasite and may have utility as a transmission blocking agent. We aimed to characterize the transmission blocking activity of low-dose tafenoquine. METHODS: Healthy adults were inoculated with Plasmodium falciparum 3D7-infected erythrocytes on day 0. Piperaquine was administered on days 9 and 11 to clear asexual parasitemia while allowing gametocyte development. A single 50-mg oral dose of tafenoquine was administered on day 25. Transmission was determined by enriched membrane feeding assays predose and at 1, 4, and 7 days postdose. Artemether-lumefantrine was administered following the final assay. Outcomes were the reduction in mosquito infection and gametocytemia after tafenoquine and safety parameters. RESULTS: Six participants were enrolled, and all were infective to mosquitoes before tafenoquine, with a median 86% (range, 22-98) of mosquitoes positive for oocysts and 57% (range, 4-92) positive for sporozoites. By day 4 after tafenoquine, the oocyst and sporozoite positivity rate had reduced by a median 35% (interquartile range [IQR]: 16-46) and 52% (IQR: 40-62), respectively, and by day 7, 81% (IQR 36-92) and 77% (IQR 52-98), respectively. The decline in gametocyte density after tafenoquine was not significant. No significant participant safety concerns were identified. CONCLUSIONS: Low-dose tafenoquine (50 mg) reduces P. falciparum transmission to mosquitoes, with a delay in effect.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Webster R, Mitchell H, Peters JM, et al. Transmission Blocking Activity of Low-dose Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum. Clin Infect Dis. 2023. PMID: 35731843. doi:10.1093/cid/ciac503

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。